A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder

NCT01640002 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder Associated With HTLV-1

Interventions

DRUG: Propantheline Bromide
DRUG: Placebo

Sponsor

Hospital Universitário Professor Edgard Santos